C

Curvebeam AI Ltd
ASX:CVB

Watchlist Manager
Curvebeam AI Ltd
ASX:CVB
Watchlist
Price: 0.071 AUD 1.43% Market Closed
Market Cap: 27.5m AUD

Relative Value

The Relative Value of one CVB stock under the Base Case scenario is 0.295 AUD. Compared to the current market price of 0.071 AUD, Curvebeam AI Ltd is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CVB Relative Value
Base Case
0.295 AUD
Undervaluation 76%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
72
vs Industry
23
Median 3Y
5.6
Median 5Y
5.6
Industry
2.3
Forward
2.4
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
22
Forward
-1.9
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
14.3
vs History
vs Industry
Median 3Y
-3
Median 5Y
-3
Industry
20
vs History
72
vs Industry
60
Median 3Y
1.1
Median 5Y
1.1
Industry
2.2
vs History
72
vs Industry
19
Median 3Y
6.5
Median 5Y
6.5
Industry
2.4
Forward
2.9
vs History
72
vs Industry
13
Median 3Y
14.2
Median 5Y
14.2
Industry
5
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
11.6
Forward
-3
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
15.9
Forward
-2
vs History
vs Industry
Median 3Y
-3
Median 5Y
-3
Industry
14.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.9
Industry
18
vs History
88
vs Industry
61
Median 3Y
1.1
Median 5Y
1.1
Industry
1.8

Multiples Across Competitors

CVB Competitors Multiples
Curvebeam AI Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Curvebeam AI Ltd
ASX:CVB
27.5m AUD 3.5 -1.4 -1.8 -1.8
US
Abbott Laboratories
NYSE:ABT
227.8B USD 5.4 16.9 21.9 31.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
184.2B USD 21.1 74.4 59.9 72.9
US
Boston Scientific Corp
NYSE:BSX
153.3B USD 8.7 75.4 35.6 49.5
US
Stryker Corp
NYSE:SYK
149B USD 6.4 52.1 25.7 31
IE
Medtronic PLC
NYSE:MDT
114.1B USD 3.4 24.5 13.7 19.5
DE
Siemens Healthineers AG
XETRA:SHL
51.8B EUR 2.2 24.8 13.9 19.3
US
Becton Dickinson and Co
NYSE:BDX
51.4B USD 2.5 33.9 13.4 25.1
US
Edwards Lifesciences Corp
NYSE:EW
45.7B USD 8.3 10.9 25.1 27.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.8B USD 10.9 47.8 33.9 37.9
US
Resmed Inc
NYSE:RMD
37B USD 7.4 28.2 20.1 22.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Curvebeam AI Ltd
ASX:CVB
Average EV/EBITDA: 26.3
Negative Multiple: -1.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.9
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.9
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.6
21%
1.7
US
Stryker Corp
NYSE:SYK
25.7
12%
2.1
IE
Medtronic PLC
NYSE:MDT
13.7
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
13.9
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.4
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
25.1
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.9
12%
2.8
US
Resmed Inc
NYSE:RMD
20.1
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Curvebeam AI Ltd
ASX:CVB
Average EV/EBIT: 33.7
Negative Multiple: -1.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.4
22%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
72.9
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.5
31%
1.6
US
Stryker Corp
NYSE:SYK
31
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.5
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.3
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25.1
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.6
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.9
12%
3.2
US
Resmed Inc
NYSE:RMD
22.8
14%
1.6